Melanoma

 

Melanoma Oncology Research Studies

RANDOMIZED PHASE II/III STUDY OF NIVOLUMAB PLUS IPILIMUMAB PLUS SARGRAMOSTIM VERSUS NIVOLUMAB PLUS IPILIMUMAB IN PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA
EA6141

Contact Us

Give us a call to learn more about our oncology research studies.